Formats
  1. Journal Article (66894)
  2. Meeting Abstract (33621)
  3. Book Section (5097)
  4. Review (3749)
  5. Editorial (2165)
  6. Conference Paper (1526)
  7. Correspondence (663)
  8. Guidelines (661)
  9. Research Letter (548)
  10. Book Whole (344)
  11. Miscellaneous (339)
Groups
  1. Department of Medicine (39043)
  2. GSK Faculty (22462)
  3. Solid Tumor Oncology Division (22061)
  4. Surgery (21262)
  5. Survivorship Research (15766)
  6. Sloan Kettering Institute Faculty (15652)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (2139)
  2. 2024 (5384)
  3. 2023 (5806)
  4. 2022 (6169)
  5. 2021 (5714)
  6. 2020 (5618)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4951)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2611)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1814)

More Publications

Publishers
  1. Elsevier Inc. (13846)
  2. American Society of Clinical Oncology (9169)
  3. Springer (7192)
  4. Nature Publishing Group (6375)
  5. American Association for Cancer Research (6014)
  6. Elsevier Science, Inc. (5512)

More Publishers

Results (115607)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Physician graded toxicity profiles and survival outcomes among patients with non-metastatic oropharyngeal carcinoma treated with proton therapy vs. intensity-modulated radiation therapy
    Meeting Abstract

    Youssef, I.; Yoon, J. J.; Zakeri, K.; Cohen, M.; Wong, R. J.; Yu, Y.; Kang, J. J.; Gelblum, D.; McBride, S. M.; Sherman, E.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Cost-effectiveness analysis of ultra-short whole breast radiation therapy alone vs. endocrine only or combined treatment for low-risk ER-positive early-stage breast cancer in women age 70 and older
    Meeting Abstract

    Ward, M. C.; Recht, A.; Vicini, F. A.; Al-Hilli, Z.; Chadha, M.; Hayman, J. A.; Thaker, N. G.; Khan, A. J.; Keisch, M. E.; Shah, C. S.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Value-based cancer care: How are we training future radiation oncologists on the quality/cost equation?
    Meeting Abstract

    Bell, L.; Chino, F.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Price variability of standard radiotherapy procedure codes in a large metropolitan area from 2015-2021
    Meeting Abstract

    Giap, F.; Hussaini, S. M. Q.; Vaughn, R.; Johnson, J. M.; Chino, F.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Trends in IMRT utilization for definitive treatment of cervical cancer, 2004-2018
    Meeting Abstract

    Lee, S. S.; Weil, C. R.; Boyd, L.; Burt, L. M. Jr; Chino, F.; Gaffney, D. K.; Shaikh, F.; Suneja, G.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • A survey of Children's Oncology Group Hodgkin Lymphoma members regarding the role of radiotherapy in the management of pediatric relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Vega, R. M.; Harker-Murray, P. D.; Forlenza, C. J.; Cole, P.; Kelly, K. M.; Milgrom, S. A.; Parikh, R. R.; Hodgson, D.; Castellino, S.; Hoppe, B. S.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose rate (HDR) vs. low-dose rate (LDR) brachytherapy boost
    Meeting Abstract

    Kollmeier, M. A.; Gorovets, D.; Flynn, J.; McBride, S.; Brennan, V. S.; Beaudry, J.; Cohen, G.; Damato, A. L.; Zhang, Z.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Preliminary analysis of concurrent programmed cell death-1 inhibitor combination with chemoradiation for recurrent/metastatic nasopharyngeal carcinoma patients: A phase II study
    Meeting Abstract

    Feng, M.; Chen, L.; Li, L.; Fan, M.; Lai, X.; Lan, M.; Xu, P.; Yin, J.; Lu, S.; Du, X.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Treatment outcomes for radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer
    Meeting Abstract

    Han, J.; Zakeri, K.; Raab, G.; Chen, L.; Yu, Y.; Kang, J. J.; McBride, S.; Riaz, N.; Tsai, C. J.; Gelblum, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Tumor volume predicts for baseline hypoxia status in HPV related oropharyngeal carcinomas (OPC) that underwent major radiation de-escalation: The 30 Reduction in Oropharyngeal Cancer Trial
    Meeting Abstract

    Han, J.; Diplas, B.; Paudyal, R.; Oh, J. H.; Sherman, E.; Schoder, H.; Hatzoglou, V.; Yu, Y.; Wong, R. J.; Wray, R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save